5-Hydroxytryptamine (5-HT) receptor antagonists for use in the treatment of inflammatory bowel syndrome (IBS)

摘要

Use of a 5-HT3 receptor antagonist or a pharmaceutically acceptable derivate thereof selected from granisetron, azasetron, tropisetron, ramosetron, ondansetron, leristeron, (R) zacopride, cilansetron, itasetron, indisetron or dolasetron in the manufacture of a medicament for the treatment of nonconstipated female irritable bowel syndrome.